Investigators concluded that the encouraging oncologic outcomes coupled with a favorable safety profile warrant further ...
MIAMI - Not long ago, a Stage 4 pancreatic cancer diagnosis was considered a death sentence. But survival rates are improving and one Miami man is living proof! Manny Garcia has a second chance at ...
A US Navy veteran who one day began having severe chest and back pain was diagnosed with stage 2 pancreatic cancer—one of the deadliest. According to doctors, the symptoms she had were completely ...
FDA approves zenocutuzumab for advanced non-small-cell lung cancer and pancreatic cancer with NRG1 fusion, offering new hope ...
By Lauren Pastrana Click here for updates on this story MIAMI (WFOR) — Not long ago, a Stage 4 pancreatic cancer diagnosis was considered a death sentence. But survival rates are improving and one ...
An FDA-approved drug used to treat multiple myeloma and lymphoma also shrank tumors in non-small cell lung cancer (NSCLC) ...
Merck (NYSE:MRK) said a Phase 3 study of its drug Keytruda in the treatment of a certain type of ovarian cancer met its ...
The selection of this first target is a key step for the partnership between Medigene and WuXi Biologics, which aims to advance multiple TCR-TCEs over the next three years. The collaboration seeks to ...
Intech Investment Management LLC purchased a new stake in shares of Zentalis Pharmaceuticals, Inc. (NASDAQ:ZNTL – Free Report) in the third quarter, HoldingsChannel.com reports. The institutional ...
For the second time this year, University of Pennsylvania spinout Carisma Therapeutics is cutting jobs and narrowing its ...
Press Release Distributed by ABNewswire.com To view the original version on ABNewswire visit: Rare NRG1 Fusion Therapeutics ...